Daubert in Doubt: Devising a Plan for New Rule 702 Implementation and Working with Experts After the Recent Amendments

The firm’s Drug and Medical Device practice group sponsored the American Conference Institute (ACI) Drug & Medical Device Litigation Conference held at the NY Marriott Marquis in New York City. J.T. Larson participated on a panel, “Daubert in Doubt: Devising a Plan for New Rule 702 Implementation and Working with Experts After the Recent Amendments.” J.T. was joined by Leah Lorber, assistant general counsel at GlaxoSmithKline, and Maureen Barber of Morgan, Lewis & Bockius. Robyn Maguire, Bill Essig, Sarah Jin, Tim Hudson, Beth Behrens, Kara Kapke, Donald Thomas, Meredith Thornburgh White, Nicole Arello, Tom Zelante, Mike Zogby, Nicole Turner, Mitch Charchalis, Kat Januszkiewicz, Nadine Kohane, Jordan Ollestad, Aliya Klein, Molly Flynn, Chanda Miller, Matt Wells, Sandra Ko and Paul Quincy attended the conference. Those in attendance also participated in a mixer that the firm co-sponsored along with peer firms.